Interleukin-6 Receptor Blockade can Increase the Risk of Nonalcoholic Fatty Liver Disease: Indications From Mendelian Randomization

Added 52 days ago (24.06.2022)

Authors: Shuxuan Li; Lanlan Chen; Guoyue Lv